Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharmascience Acquires Aegera | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pharmascience Acquires Aegera

Pharmascience, a generic pharmaceutical company basin in Quebec, has acquired Aegera Therapeutics, a Montreal-based clinical-stage biotechnology company focused on developing therapeutics to address unmet medical needs, primarily in oncology.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharmascience, a generic pharmaceutical company basin in Quebec, has acquired Aegera Therapeutics, a Montreal-based clinical-stage biotechnology company focused on developing therapeutics to address unmet medical needs, primarily in oncology. Aegera’s 20 employees will join Pharmascience.

“The acquisition of Aegera will enable Pharmascience to increase and diversify its research and development activities through the continuance of Aegera’s programs,” said David Goodman, chief executive officer of Pharmascience. This acquisition will strengthen Pharmascience’s position as a pharmaceutical leader, and will solidify our organization’s diversification and expansion strategy.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters